Leaky gut refers to a real physiological condition in which the lining of your small intestine becomes more porous than it should be, allowing substances like bacteria, toxins, and partially digested food particles to pass into your bloodstream. The medical term is “increased intestinal permeability.” While the phenomenon itself is well documented in research, “leaky gut syndrome” is not currently a recognized medical diagnosis. That distinction matters: doctors agree the intestinal lining can become too permeable, but there’s ongoing debate about whether that permeability is a cause of disease or a consequence of it.
How Your Gut Barrier Works
Your intestinal lining is just one cell layer thick. These cells are held together by structures called tight junctions, which act like selective gates between cells. Tight junctions are built from transmembrane proteins (the physical barrier) and scaffolding proteins that anchor everything to the cell’s internal skeleton. Together, they form a seal that controls what passes through the gaps between cells and what stays out.
When functioning properly, tight junctions allow water, nutrients, and small molecules to cross into your bloodstream while blocking larger, potentially harmful substances like bacterial toxins. The “pore pathway” through these junctions restricts anything that’s too large or carries a charge from slipping through. This selectivity is what keeps your immune system from being constantly bombarded by the contents of your digestive tract.
A protein called zonulin is the only known molecule your body produces that directly opens these tight junctions on purpose. Think of it as a key that temporarily unlocks the gates. In small, controlled amounts, zonulin helps regulate the normal flow of molecules across the intestinal wall. Problems start when zonulin is released in excess or when the tight junction proteins are damaged by other forces.
What Triggers Increased Permeability
Several well-studied factors can loosen or damage tight junctions. Most cases of increased intestinal permeability involve more than one of these working together.
Gliadin and Gluten
Gliadin, a protein found in wheat gluten, triggers zonulin release by binding to a specific receptor on intestinal cells. This sets off a signaling chain that causes tight junctions to disassemble, widening the gaps between cells. In one study, gliadin administration alone produced a 4.3-fold increase in intestinal permeability, even without any other damaging agent present. This effect is most pronounced in people with celiac disease, but research shows it occurs to some degree in others as well.
NSAIDs and Common Painkillers
Over-the-counter anti-inflammatory drugs like ibuprofen and naproxen damage the gut lining through a two-step process. First, their chemical properties (they’re lipid-soluble weak acids) give them a detergent-like effect that disrupts the protective layer of fats coating intestinal cells. Second, they interfere with energy production inside those cells by uncoupling a process called oxidative phosphorylation. The combined result is direct cellular damage and increased permeability. Once the barrier is compromised, bile and bacteria in the small intestine amplify the damage, leading to low-grade inflammation, erosions, and sometimes ulcers.
Gut Bacteria Imbalances
Your intestine houses trillions of bacteria, and the balance between beneficial and harmful species plays a direct role in barrier integrity. When that balance shifts toward harmful bacteria, a condition called dysbiosis, the intestinal lining takes a hit from multiple directions. Dysbiosis reduces production of antimicrobial compounds and a protective antibody called secretory IgA, both of which normally reinforce the barrier. At the same time, harmful bacteria expose the intestinal wall to inflammatory molecules like lipopolysaccharides (LPS). When LPS crosses into the bloodstream through weakened tight junctions, it triggers immune receptors throughout the body, producing low-grade systemic inflammation that has been linked to conditions ranging from metabolic syndrome to skin and lung problems.
Inflammatory Signaling
Several inflammatory molecules, including TNF-alpha, interferon-gamma, and IL-1 beta, directly increase tight junction permeability by activating an enzyme that controls the structural tension of intestinal cells. This means that any condition producing chronic inflammation, whether from infection, autoimmune disease, or prolonged stress, can make the gut barrier more porous. It’s a feedback loop: inflammation opens the barrier, and a more open barrier lets in substances that cause more inflammation.
Heat and Physical Stress
Extreme physical exertion and heat exposure are also documented causes. A leaky tight junction barrier is described as a hallmark of both exertional stress and heat stroke in research. This is one reason gastrointestinal symptoms are common among endurance athletes.
Why It’s Not Yet a Medical Diagnosis
The Cleveland Clinic summarizes the situation clearly: increased intestinal permeability is real, but there’s no consensus that it’s a standalone disease or that it directly causes other diseases. Part of the difficulty is measurement. There is no standard clinical test for intestinal permeability that doctors can order the way they’d order a blood sugar check.
The closest thing is the lactulose-mannitol test, a research tool where you drink a solution containing two sugars after an overnight fast, then collect urine for several hours. One sugar (mannitol) is small and passes through the intestinal wall easily. The other (lactulose) is larger and should mostly be blocked by healthy tight junctions. The ratio of the two sugars in your urine indicates how permeable your gut is. In healthy people, the median ratio is about 0.03, but every lab has to establish its own reference range, which is one reason this test hasn’t become a standard diagnostic tool.
Without a reliable, standardized test, it’s difficult for clinicians to diagnose increased permeability, track it over time, or definitively prove it caused a patient’s symptoms. This is the gap between what researchers observe in the lab and what your doctor can act on in a clinical setting.
Conditions Associated With Increased Permeability
Increased intestinal permeability has been documented in a wide range of conditions. Celiac disease is the most clearly established connection, with gliadin directly triggering zonulin release and barrier breakdown. But researchers have also observed increased permeability in inflammatory bowel disease, irritable bowel syndrome, type 1 diabetes, and various autoimmune conditions. The recurring question is whether the permeability came first or resulted from the disease itself. In celiac disease, the evidence for a causal role is strongest. In other conditions, the picture is less clear.
What Helps Restore the Gut Barrier
Because leaky gut isn’t an official diagnosis, there’s no standardized treatment protocol. Most approaches focus on removing known triggers and supporting the intestinal lining’s natural repair process.
Reducing or eliminating NSAID use, when possible, removes one of the most direct sources of barrier damage. For people sensitive to gluten, limiting exposure reduces the zonulin release that opens tight junctions. Addressing dysbiosis through dietary changes that promote beneficial bacteria, such as increasing fiber intake and fermented foods, helps restore the protective microbial layer.
Glutamine, an amino acid that intestinal cells use as their primary fuel source, is one of the few supplements with clinical backing. The Mayo Clinic notes its use alongside specialized diets for short bowel syndrome at doses of 30 grams per day in divided doses, though this specific application is for a severe condition. Lower doses are widely used in integrative medicine for general gut support, but large-scale clinical trials for “leaky gut” specifically are limited.
Researchers are also investigating a compound called larazotide, which works by blocking the zonulin receptor and preventing tight junctions from opening. It’s currently in a Phase 2 clinical trial for long COVID symptoms, based on the theory that increased intestinal permeability plays a role in that condition. No efficacy results are available yet, with the trial expected to complete in 2026.
The most practical steps for most people come down to basics: reducing chronic use of painkillers that damage the gut lining, eating a diet that supports diverse gut bacteria, managing sources of chronic inflammation, and limiting alcohol, which also increases permeability through direct damage to intestinal cells. These won’t produce overnight results. The intestinal lining replaces itself roughly every three to five days, but restoring a healthy barrier when the underlying causes have been chronic takes longer.